BRIEF published on 04/10/2025 at 19:05, 1 year 2 months ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 2 months ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 year 3 months ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 1 year 4 months ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
PRESS RELEASE published on 01/29/2025 at 08:00, 1 year 4 months ago Inside Information / Other news releases TME Pharma collaborates with aimed analytics for AI-driven drug discovery, strengthening capabilities for strategic transactions. The partnership utilizes AI to accelerate drug development and optimize existing therapies Strategic Partnerships Cancer Treatment TME Pharma AI-driven Drug Discovery Aimed Analytics
BRIEF published on 12/23/2024 at 21:09, 1 year 5 months ago Successful public offering of TME Pharma NV Shareholders Capital Increase Cancer Financial Strategies NOX-A12
BRIEF published on 12/04/2024 at 19:55, 1 year 6 months ago TME Pharma Announces Strategic Update and €2.6 Million Financing Plan Public Offer Corporate Strategy Financing Plan NOX-A12 Development Shareholder Priority
PRESS RELEASE published on 12/04/2024 at 19:50, 1 year 6 months ago Inside Information / Other news releases TME Pharma announces corporate strategy update with upcoming €2.6 million financing aimed at further developing therapies for cancer treatment through public offer open to shareholders. CEO Mangasarian highlights strategic goals and plans Financing Cancer Treatment Public Offer Corporate Strategy TME Pharma
BRIEF published on 11/23/2024 at 10:59, 1 year 6 months ago TME Pharma Presents Findings on NOX-A12 in Glioblastoma Cancer Therapy Glioblastoma NOX-A12 Immune Checkpoint Inhibition Tumor Microenvironment
Published on 06/13/2026 at 04:50, 5 hours 12 minutes ago BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 8 hours 2 minutes ago Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 10 hours 47 minutes ago BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 11 hours 32 minutes ago Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 18 hours 48 minutes ago Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders
Published on 06/13/2026 at 08:18, 1 hour 44 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 8 hours 57 minutes ago OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
Published on 06/12/2026 at 22:50, 11 hours 12 minutes ago Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock
Published on 06/12/2026 at 21:00, 13 hours 2 minutes ago Partners Group statement regarding its evergreen vehicles
Published on 06/12/2026 at 20:22, 13 hours 40 minutes ago Rumble Announces Discontinuation of Trading in Tendered Northern Data Shares (ISIN DE000A41YEL8) in the Exchange Offer
Published on 06/12/2026 at 18:31, 15 hours 30 minutes ago Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 09:00, 1 day 1 hour ago Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 17:45, 1 day 16 hours ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
